Goserelin Acetate Patent Expiration

Goserelin Acetate was first introduced by Tersera Therapeutics Llc in its drug Zoladex on Dec 29, 1989.


Goserelin Acetate Patents

Given below is the list of patents protecting Goserelin Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Zoladex US7118552 Automatically operable safety shield system for syringes Apr 13, 2022

(Expired)

Tersera
Zoladex US7220247 Automatically operable safety shield system for syringes Apr 09, 2022

(Expired)

Tersera
Zoladex US7500964 Automatically operable safety shield system for syringes Feb 26, 2021

(Expired)

Tersera



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Goserelin Acetate's patents.

Given below is the list recent legal activities going on the following patents of Goserelin Acetate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 13 Aug, 2020 US7500964
Payment of Maintenance Fee, 12th Year, Large Entity 16 Oct, 2018 US7220247
Payment of Maintenance Fee, 12th Year, Large Entity 13 Mar, 2018 US7118552
Email Notification 07 Jun, 2017 US7500964
Change in Power of Attorney (May Include Associate POA) 07 Jun, 2017 US7500964
Correspondence Address Change 05 Jun, 2017 US7500964
Electronic Review 30 May, 2017 US7500964
Email Notification 26 May, 2017 US7500964
Mail Pre-Exam Notice 26 May, 2017 US7500964
Change in Power of Attorney (May Include Associate POA) 24 May, 2017 US7118552


Goserelin Acetate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List